drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Pine needle extract improves depression-like symptoms Mechanism of neuroprotection and neurotransmitter regulation via activation of the apelin pathway elucidated for the first time
Arakawa Chemical Industries, Ltd. (Headquarters: Chuo-ku, Osaka; President: Nobuyuki Takagi) and a research team including MED R&D Inc. (Headquarters: Tsukuba City, Ibaraki Prefecture; President: Hiroko Isoda), a venture company originating from the University of Tsukuba, has demonstrated that an extract from Japanese red pine needles (Pinus densiflora) effectively reduces immobility time, exerts neuroprotective effects, and modulates neurotransmitters in a mouse model exhibiting depression-like symptoms. This study is the first to demonstrate that pine needle extract activates the apelin signaling pathway, thereby suppressing neuroinflammation, promoting the production of brain-derived neurotrophic factor (BDNF), and improving neurotransmitter production.
BASF and IFF Launch Strategic Partnership for Next-Gen Enzyme and Polymer Innovations
The aim of the collaboration between BASF and IFF is to accelerate the development of IFF's Designed Enzymatic Biomaterials technology platform and to develop next-generation enzyme technologies for applications in detergents, industrial cleaning and personal care products.
The Impact of Aromatherapy's Calming Effects on Sleep Quality and Skin Condition
Mandom Corporation (Headquarters: Osaka City; President and CEO: Ken Nishimura; hereinafter "Mandom"), a "people-oriented" company, strives to create new value that delights, inspires, and puts smiles on consumers' faces. We conduct a variety of sensory research to enhance the emotional value of our products, not just their functional value. Mandom has previously demonstrated that certain fragrances have a calming (relaxing) effect on the autonomic and central nervous systems. In this study, we found that consumers experiencing stress and sleep problems who continued to use skin care products containing these fragrances experienced improved sleep quality, shorter sleep onset times, and improved skin radiance. These results suggest that the relaxing effects of fragrances may have a positive impact on sleep and skin condition in everyday life, providing new insights toward realizing "skin care that delights the skin and the mind." These research results were presented at the 27th Annual Meeting of the Japan Society of Kansei Engineering, held from September 17th to 19th, 2025.
Precision Fermented Dairy Proteins Receive ‘No Questions’ Approval From FDA
Verley has received a “no-questions” approval letter from the FDA for its precision fermented dairy proteins. The French startup, formerly known as Bon Vivant, is now one step closer to introducing its novel alternative dairy ingredients to the US market.
Presentation of data from the oncology portfolio at the 2025 European Society for Medical Oncology (ESMO) Congress
Astellas Pharma Inc. (Headquarters: Tokyo; President and CEO: Naoki Okamura; hereinafter “Astellas”) will present 10 updates on the progress of its oncology portfolio and pipeline at the 2025 European Society for Medical Oncology (ESMO) Congress, held from October 17 to 21. New data on the combination therapy of PADCEV™ (generic name: enholzumab vedotin (recombinant)) and Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the U.S. and Canada), will be presented at the ESMO Presidential Symposium on October 18 (local time). We will present new favorable data on overall survival for XTANDITM (generic name: enzalutamide) in patients with non-metastatic hormone-sensitive prostate cancer at high risk of biochemical recurrence. We also plan to present data on ASP2138, a next-generation bispecific T-cell engager, in solid tumors. Astellas will continue to demonstrate leadership in precision medicine targeting CLDN18.2.
Insects “Eat” Sewage Sludge and Convert It into Energy Resources New Technology Utilizes Insects to Recycle Sludge Generated at Sewage Treatment Plants
Super Worm Co., Ltd. (Headquarters: Saito City, Miyazaki Prefecture; President: Yutaro Koga) has commenced joint research with Water ing Co., Ltd. (Headquarters: Minato-ku, Tokyo; President: Maki Yasuda) on a new technology to reduce the volume and convert sludge generated at sewage treatment plants into resources using insects. This joint research began on October 1, 2025. This research will verify the sludge reduction efficiency and the potential for resource utilization of fats and proteins accumulated within insects as insects such as Superworms and mealworms consume and grow on the sludge. It aims to contribute to the realization of a decarbonized society and a circular economy by developing a new, environmentally friendly treatment method to replace conventional incineration and landfill disposal.
Confirmed enhanced ability of saliva to inactivate influenza viruses
Lion Corporation (President and CEO: Masayuki Takemori) has demonstrated that brushing teeth enhances the ability of saliva to inactivate influenza viruses. This effect was particularly pronounced in individuals who experienced a reduction in total oral bacteria count. This finding suggests that meticulous daily brushing can help maintain oral health and potentially reduce the risk of infectious diseases. This study is the first in the world to demonstrate that brushing teeth enhances the inactivation ability of influenza virus in saliva※1. It was published in the scientific journal BDJ Open, issued by the British Dental Journal, on July 19, 2025.
Joint Demonstration Experiment to Convert Cosmetics-Specific “Non-Biodegradable” Waste Liquids into Energy
Saishunkan Pharmaceutical Co., Ltd. (Headquarters: Mashiki Town, Kamimashiki District, Kumamoto Prefecture; President and CEO: Masaaki Nishikawa; hereinafter “Saishunkan Pharmaceutical”) announces the commencement of a joint demonstration experiment with Watasumi Co., Ltd. (Headquarters: Onna Village, Kunigami District, Okinawa Prefecture; CEO: David Simpson; hereinafter “Watasumi”), a startup originating from the Okinawa Institute of Science and Technology Graduate University (OIST).  This collaboration will utilize Watasumi's microbial fuel cell technology to decompose high-concentration cosmetic waste liquids containing preservatives, diverse oils, and powders—substances previously difficult to treat—while simultaneously generating renewable energy such as biogas and electricity. This aims to fundamentally reduce the environmental impact of business activities and establish a circular model for a sustainable future in the cosmetics industry.
World's First: Butyrate-Producing Bacteria That Do Not Produce Formic Acid
Highmount Co., Ltd. (Headquarters: Gifu City, Gifu Prefecture; President: Hirotaka Koyama) announces that it has obtained a patent from the Japan Patent Office for a “new strain of Clostridium butyricum possessing butyrate production capability,” developed through approximately 40 years of proprietary research.
Decarbonization Technologies for Carbon Neutrality: Unraveling the Path from Carbon Reduction Potential
Astamuse Inc. (Headquarters: Chiyoda-ku, Tokyo; President: Ayumi Nagai) has reorganized the technology domains contributing to carbon reduction by providing a comprehensive overview of technologies for realizing a decarbonized society. We are now announcing this new technology classification (Table 1). In 2021, Astamuse independently organized and published 40 carbon reduction technology areas. In June 2022, following the announcement of the “Green Transformation Technologies Inventory (GXTI)” by the Patent Office, Astamuse also clearly indicated the correspondence with its own technology areas.
Detects E. coli in minutes Gold-plated sensor and smartphone-sized board-mounted analyzer
A pocket-sized device developed by a research team at the University of Waterloo features technology to rapidly and inexpensively detect water contamination. Specializing in detecting E. coli, the device uses a gold-plated sensor and a vector network analyzer (VNA) mounted on a smartphone-sized board to provide instant detection using just a few drops of water. Developed to reduce the risk of infectious diseases, this technology has the potential to make a significant impact, particularly in developing countries where water testing is challenging.
自己修復性と抗菌性を備えた植物由来プラスチック 可視光で光硬化し室温で光学3Dプリント可能
Researchers at Kaunas University of Technology (Lithuania) have announced the development of a plant-derived plastic (Vitrimer) that combines self-healing properties with antimicrobial capabilities. This material photopolymerizes under UV or visible light, requires no catalyst for processing, enables optical 3D printing at room temperature, and is suitable for precision components in medical devices and optical parts. Furthermore, components derived from biodiesel byproducts disrupt bacterial function, making it an environmentally friendly multifunctional material suitable for hygienic applications.
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm
HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough Device designation for its Aortic Stenosis (“AS”) ECG algorithm. Aortic Stenosis is one of the most serious and common heart valve diseases, often progressing silently and leading to severe, life-threatening outcomes if left undetected. Early symptoms are frequently vague or absent, resulting in delayed diagnosis and treatment. If unrecognized, AS can cause irreversible myocardial damage and significant deterioration in cardiac function. The algorithm would offer a novel, AI-driven ECG solution capable of detecting moderate-to-severe aortic stenosis. Once cleared by the FDA, the algorithm will be accessible through HeartSciences' MyoVista Insights cloud-based platform which would directly integrate with hospital electronic health record (EHR) systems, requiring no additional hardware or testing.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
Pine needle extract improves depression-like symptoms Mechanism of neuroprotection and neurotransmitter regulation via activation of the apelin pathway elucidated for the first time
Arakawa Chemical Industries, Ltd. (Headquarters: Chuo-ku, Osaka; President: Nobuyuki Takagi) and a research team including MED R&D Inc. (Headquarters: Tsukuba City, Ibaraki Prefecture; President: Hiroko Isoda), a venture company originating from the University of Tsukuba, has demonstrated that an extract from Japanese red pine needles (Pinus densiflora) effectively reduces immobility time, exerts neuroprotective effects, and modulates neurotransmitters in a mouse model exhibiting depression-like symptoms. This study is the first to demonstrate that pine needle extract activates the apelin signaling pathway, thereby suppressing neuroinflammation, promoting the production of brain-derived neurotrophic factor (BDNF), and improving neurotransmitter production.
PR TIMES
BASF and IFF Launch Strategic Partnership for Next-Gen Enzyme and Polymer Innovations
The aim of the collaboration between BASF and IFF is to accelerate the development of IFF's Designed Enzymatic Biomaterials technology platform and to develop next-generation enzyme technologies for applications in detergents, industrial cleaning and personal care products.
CHEManager International
The Impact of Aromatherapy's Calming Effects on Sleep Quality and Skin Condition
Mandom Corporation (Headquarters: Osaka City; President and CEO: Ken Nishimura; hereinafter "Mandom"), a "people-oriented" company, strives to create new value that delights, inspires, and puts smiles on consumers' faces. We conduct a variety of sensory research to enhance the emotional value of our products, not just their functional value. Mandom has previously demonstrated that certain fragrances have a calming (relaxing) effect on the autonomic and central nervous systems. In this study, we found that consumers experiencing stress and sleep problems who continued to use skin care products containing these fragrances experienced improved sleep quality, shorter sleep onset times, and improved skin radiance. These results suggest that the relaxing effects of fragrances may have a positive impact on sleep and skin condition in everyday life, providing new insights toward realizing "skin care that delights the skin and the mind." These research results were presented at the 27th Annual Meeting of the Japan Society of Kansei Engineering, held from September 17th to 19th, 2025.
PR TIMES
Precision Fermented Dairy Proteins Receive ‘No Questions’ Approval From FDA
Verley has received a “no-questions” approval letter from the FDA for its precision fermented dairy proteins. The French startup, formerly known as Bon Vivant, is now one step closer to introducing its novel alternative dairy ingredients to the US market.
Plant Based News
Presentation of data from the oncology portfolio at the 2025 European Society for Medical Oncology (ESMO) Congress
Astellas Pharma Inc. (Headquarters: Tokyo; President and CEO: Naoki Okamura; hereinafter “Astellas”) will present 10 updates on the progress of its oncology portfolio and pipeline at the 2025 European Society for Medical Oncology (ESMO) Congress, held from October 17 to 21. New data on the combination therapy of PADCEV™ (generic name: enholzumab vedotin (recombinant)) and Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the U.S. and Canada), will be presented at the ESMO Presidential Symposium on October 18 (local time). We will present new favorable data on overall survival for XTANDITM (generic name: enzalutamide) in patients with non-metastatic hormone-sensitive prostate cancer at high risk of biochemical recurrence. We also plan to present data on ASP2138, a next-generation bispecific T-cell engager, in solid tumors. Astellas will continue to demonstrate leadership in precision medicine targeting CLDN18.2.
アステラス製薬株式会社
Insects “Eat” Sewage Sludge and Convert It into Energy Resources New Technology Utilizes Insects to Recycle Sludge Generated at Sewage Treatment Plants
Super Worm Co., Ltd. (Headquarters: Saito City, Miyazaki Prefecture; President: Yutaro Koga) has commenced joint research with Water ing Co., Ltd. (Headquarters: Minato-ku, Tokyo; President: Maki Yasuda) on a new technology to reduce the volume and convert sludge generated at sewage treatment plants into resources using insects. This joint research began on October 1, 2025. This research will verify the sludge reduction efficiency and the potential for resource utilization of fats and proteins accumulated within insects as insects such as Superworms and mealworms consume and grow on the sludge. It aims to contribute to the realization of a decarbonized society and a circular economy by developing a new, environmentally friendly treatment method to replace conventional incineration and landfill disposal.
PR TIMES
Confirmed enhanced ability of saliva to inactivate influenza viruses
Lion Corporation (President and CEO: Masayuki Takemori) has demonstrated that brushing teeth enhances the ability of saliva to inactivate influenza viruses. This effect was particularly pronounced in individuals who experienced a reduction in total oral bacteria count. This finding suggests that meticulous daily brushing can help maintain oral health and potentially reduce the risk of infectious diseases. This study is the first in the world to demonstrate that brushing teeth enhances the inactivation ability of influenza virus in saliva※1. It was published in the scientific journal BDJ Open, issued by the British Dental Journal, on July 19, 2025.
ライオン株式会社
Joint Demonstration Experiment to Convert Cosmetics-Specific “Non-Biodegradable” Waste Liquids into Energy
Saishunkan Pharmaceutical Co., Ltd. (Headquarters: Mashiki Town, Kamimashiki District, Kumamoto Prefecture; President and CEO: Masaaki Nishikawa; hereinafter “Saishunkan Pharmaceutical”) announces the commencement of a joint demonstration experiment with Watasumi Co., Ltd. (Headquarters: Onna Village, Kunigami District, Okinawa Prefecture; CEO: David Simpson; hereinafter “Watasumi”), a startup originating from the Okinawa Institute of Science and Technology Graduate University (OIST).  This collaboration will utilize Watasumi's microbial fuel cell technology to decompose high-concentration cosmetic waste liquids containing preservatives, diverse oils, and powders—substances previously difficult to treat—while simultaneously generating renewable energy such as biogas and electricity. This aims to fundamentally reduce the environmental impact of business activities and establish a circular model for a sustainable future in the cosmetics industry.
PR TIMES
World's First: Butyrate-Producing Bacteria That Do Not Produce Formic Acid
Highmount Co., Ltd. (Headquarters: Gifu City, Gifu Prefecture; President: Hirotaka Koyama) announces that it has obtained a patent from the Japan Patent Office for a “new strain of Clostridium butyricum possessing butyrate production capability,” developed through approximately 40 years of proprietary research.
PR TIMES
Decarbonization Technologies for Carbon Neutrality: Unraveling the Path from Carbon Reduction Potential
Astamuse Inc. (Headquarters: Chiyoda-ku, Tokyo; President: Ayumi Nagai) has reorganized the technology domains contributing to carbon reduction by providing a comprehensive overview of technologies for realizing a decarbonized society. We are now announcing this new technology classification (Table 1). In 2021, Astamuse independently organized and published 40 carbon reduction technology areas. In June 2022, following the announcement of the “Green Transformation Technologies Inventory (GXTI)” by the Patent Office, Astamuse also clearly indicated the correspondence with its own technology areas.
astamuse
Detects E. coli in minutes Gold-plated sensor and smartphone-sized board-mounted analyzer
A pocket-sized device developed by a research team at the University of Waterloo features technology to rapidly and inexpensively detect water contamination. Specializing in detecting E. coli, the device uses a gold-plated sensor and a vector network analyzer (VNA) mounted on a smartphone-sized board to provide instant detection using just a few drops of water. Developed to reduce the risk of infectious diseases, this technology has the potential to make a significant impact, particularly in developing countries where water testing is challenging.
Phys.org
自己修復性と抗菌性を備えた植物由来プラスチック 可視光で光硬化し室温で光学3Dプリント可能
Researchers at Kaunas University of Technology (Lithuania) have announced the development of a plant-derived plastic (Vitrimer) that combines self-healing properties with antimicrobial capabilities. This material photopolymerizes under UV or visible light, requires no catalyst for processing, enables optical 3D printing at room temperature, and is suitable for precision components in medical devices and optical parts. Furthermore, components derived from biodiesel byproducts disrupt bacterial function, making it an environmentally friendly multifunctional material suitable for hygienic applications.
Technology Networks
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm
HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough Device designation for its Aortic Stenosis (“AS”) ECG algorithm. Aortic Stenosis is one of the most serious and common heart valve diseases, often progressing silently and leading to severe, life-threatening outcomes if left undetected. Early symptoms are frequently vague or absent, resulting in delayed diagnosis and treatment. If unrecognized, AS can cause irreversible myocardial damage and significant deterioration in cardiac function. The algorithm would offer a novel, AI-driven ECG solution capable of detecting moderate-to-severe aortic stenosis. Once cleared by the FDA, the algorithm will be accessible through HeartSciences' MyoVista Insights cloud-based platform which would directly integrate with hospital electronic health record (EHR) systems, requiring no additional hardware or testing.
DAIC